Rifabutin (RHB‐105) Based Triple Therapy forHelicobacter pylori (HP)Infection Eradication: Results of Pivotal Phase 3 Multi‐Center Study (ERADICATE Hp2): 1200. (October 2019) - Graham, David Y.; Canaan, Yamil; Maher, James; Weiner, Gregory; Kalfus, Ira N.